DK3484889T3 - Ethynylderivater - Google Patents

Ethynylderivater Download PDF

Info

Publication number
DK3484889T3
DK3484889T3 DK17742971.9T DK17742971T DK3484889T3 DK 3484889 T3 DK3484889 T3 DK 3484889T3 DK 17742971 T DK17742971 T DK 17742971T DK 3484889 T3 DK3484889 T3 DK 3484889T3
Authority
DK
Denmark
Prior art keywords
ethynyl derivatives
ethynyl
derivatives
Prior art date
Application number
DK17742971.9T
Other languages
English (en)
Inventor
Barbara Biemans
Georg Jaeschke
Antonio Ricci
Daniel Rueher
Fionn O`Hara
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK3484889T3 publication Critical patent/DK3484889T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/527Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim spiro-condensed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09Geometrical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK17742971.9T 2016-07-18 2017-07-12 Ethynylderivater DK3484889T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16179837 2016-07-18
PCT/EP2017/067495 WO2018015235A1 (en) 2016-07-18 2017-07-12 Ethynyl derivatives

Publications (1)

Publication Number Publication Date
DK3484889T3 true DK3484889T3 (da) 2020-10-26

Family

ID=56418435

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17742971.9T DK3484889T3 (da) 2016-07-18 2017-07-12 Ethynylderivater

Country Status (31)

Country Link
US (3) US20190144458A1 (da)
EP (1) EP3484889B1 (da)
JP (1) JP6936305B2 (da)
KR (1) KR20190026805A (da)
CN (1) CN109476671B (da)
AR (1) AR109075A1 (da)
AU (1) AU2017299083B2 (da)
BR (1) BR112019000314A2 (da)
CA (1) CA3030788A1 (da)
CL (1) CL2019000045A1 (da)
CO (1) CO2018013824A2 (da)
CR (1) CR20190014A (da)
DK (1) DK3484889T3 (da)
ES (1) ES2826389T3 (da)
HR (1) HRP20201615T1 (da)
HU (1) HUE051006T2 (da)
IL (1) IL263884A (da)
LT (1) LT3484889T (da)
MA (1) MA45665B1 (da)
MX (1) MX2019000442A (da)
PE (1) PE20190382A1 (da)
PH (1) PH12019500119A1 (da)
PL (1) PL3484889T3 (da)
PT (1) PT3484889T (da)
RS (1) RS60908B1 (da)
RU (1) RU2745068C2 (da)
SG (1) SG11201811829QA (da)
SI (1) SI3484889T1 (da)
TW (1) TWI729169B (da)
WO (1) WO2018015235A1 (da)
ZA (1) ZA201900113B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3322701T (lt) 2015-07-15 2019-07-10 F. Hoffmann-La Roche Ag Etinilo dariniai kaip metabotropinių glutamato receptorių moduliatoriai
CN110183456A (zh) * 2019-07-11 2019-08-30 河南师范大学 一种2-芳基吲唑琥珀酰亚胺螺环化合物的合成方法
US11515154B2 (en) * 2020-10-27 2022-11-29 Applied Materials, Inc. Selective deposition of a passivation film

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060116366A1 (en) * 2002-12-04 2006-06-01 Parmee Emma R Spirocyclic ureas, compositions containing such compounds and methods of use
CA2602965C (en) 2005-05-24 2013-12-31 Laboratoires Serono S.A. Tricyclic spiro derivatives as crth2 modulators
JP2010502617A (ja) 2006-08-31 2010-01-28 シェーリング コーポレイション 抗菌物質として有用なヒダントイン誘導体
JP5622568B2 (ja) 2007-06-03 2014-11-12 バンダービルト ユニバーシティ ベンズアミドmGluR5の正のアロステリック調節因子ならびにその作製および使用方法
RU2012114770A (ru) 2009-09-04 2013-10-10 Вандербилт Юниверсити АЛЛОСТЕРИЧЕСКИЕ СРЕДСТВА ПОТЕНЦИРОВАНИЯ mGluR4, КОМПОЗИЦИИ И СПОСОБЫ ЛЕЧЕНИЯ НЕВРОЛОГИЧЕСКИХ ДИСФУНКЦИЙ
US8389536B2 (en) 2009-10-27 2013-03-05 Hoffmann-La Roche Inc. Positive allosteric modulators (PAM)
US8759377B2 (en) 2009-11-23 2014-06-24 Vanderbilt University Substituted dioxopiperidines and dioxopyrrolidines as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
US8586581B2 (en) * 2009-12-17 2013-11-19 Hoffmann-La Roche Inc Ethynyl compounds useful for treatment of CNS disorders
US8420661B2 (en) 2010-04-13 2013-04-16 Hoffmann-La Roche Inc. Arylethynyl derivatives
US8772300B2 (en) 2011-04-19 2014-07-08 Hoffmann-La Roche Inc. Phenyl or pyridinyl-ethynyl derivatives
CA2829170C (en) 2011-04-26 2019-02-26 F. Hoffmann-La Roche Ag Ethynyl derivatives as positive allosteric modulators of the mglur5
US10533000B2 (en) 2011-05-26 2020-01-14 Sunovion Pharmaceuticals, Inc. Metabotrophic glutamate receptor 5 modulators and methods of use thereof
JP6205354B2 (ja) * 2011-07-06 2017-09-27 ギリアード サイエンシーズ, インコーポレイテッド Hivの処置のための化合物
US20130123254A1 (en) 2011-09-30 2013-05-16 Barbara Biemans Pharmaceutically acceptable mglur5 positive allosteric modulators and their methods of identification
UA110862C2 (uk) 2011-10-07 2016-02-25 Ф. Хоффманн-Ля Рош Аг Похідні етинілу як алостеричні модулятори метаботропного рецептора глутамату mglur 5
NZ703537A (en) 2012-10-18 2018-06-29 Hoffmann La Roche Ethynyl derivatives
MY170152A (en) 2012-10-18 2019-07-09 Hoffmann La Roche Ethynyl derivative as modulators of mglur5 receptor activity
CN105121424B (zh) 2013-02-18 2019-01-22 华领医药技术(上海)有限公司 mGluR调节剂
UY35400A (es) 2013-03-15 2014-10-31 Novartis Ag Compuestos y composiciones para el tratamiento de enfermedades parasitarias
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
PE20160666A1 (es) 2013-09-25 2016-07-09 Hoffmann La Roche Derivados de etinilo
TWI649310B (zh) 2014-01-10 2019-02-01 赫孚孟拉羅股份公司 乙炔基衍生物
PT3110802T (pt) 2014-02-25 2018-12-04 Hoffmann La Roche Derivados de etinilo
CN104860941B (zh) 2014-02-25 2017-03-22 上海海雁医药科技有限公司 2,4‑二取代苯‑1,5‑二胺衍生物及其应用以及由其制备的药物组合物和药用组合物
EP3271353B1 (en) 2015-03-19 2019-11-27 H. Hoffnabb-La Roche Ag 3-(4-ethynylphenyl)hexahydropyrimidin-2,4-dione derivatives as modulators of mglur4
LT3322701T (lt) 2015-07-15 2019-07-10 F. Hoffmann-La Roche Ag Etinilo dariniai kaip metabotropinių glutamato receptorių moduliatoriai
US10391998B2 (en) 2016-11-16 2019-08-27 Ford Global Technologies, Llc Vehicle systems and methods for reducing electrified vehicle noise, vibration, and harshness

Also Published As

Publication number Publication date
EP3484889A1 (en) 2019-05-22
PT3484889T (pt) 2020-10-15
CA3030788A1 (en) 2018-01-25
WO2018015235A1 (en) 2018-01-25
CR20190014A (es) 2019-03-04
US20220127275A1 (en) 2022-04-28
SG11201811829QA (en) 2019-02-27
JP6936305B2 (ja) 2021-09-15
MA45665B1 (fr) 2020-11-30
ES2826389T3 (es) 2021-05-18
RS60908B1 (sr) 2020-11-30
IL263884A (en) 2019-01-31
CL2019000045A1 (es) 2019-06-07
CN109476671B (zh) 2021-09-24
AU2017299083B2 (en) 2021-06-24
TWI729169B (zh) 2021-06-01
PH12019500119A1 (en) 2019-12-11
ZA201900113B (en) 2019-09-25
CO2018013824A2 (es) 2018-12-28
SI3484889T1 (sl) 2020-11-30
AU2017299083A1 (en) 2019-01-24
PL3484889T3 (pl) 2020-12-28
KR20190026805A (ko) 2019-03-13
TW201805287A (zh) 2018-02-16
HRP20201615T1 (hr) 2020-12-11
EP3484889B1 (en) 2020-08-19
US20190144458A1 (en) 2019-05-16
CN109476671A (zh) 2019-03-15
HUE051006T2 (hu) 2021-01-28
LT3484889T (lt) 2020-11-10
RU2019102757A3 (da) 2020-08-18
BR112019000314A2 (pt) 2019-04-16
MX2019000442A (es) 2019-06-20
RU2019102757A (ru) 2020-08-18
US11242349B2 (en) 2022-02-08
JP2019521158A (ja) 2019-07-25
RU2745068C2 (ru) 2021-03-18
PE20190382A1 (es) 2019-03-08
US20200255440A1 (en) 2020-08-13
AR109075A1 (es) 2018-10-24

Similar Documents

Publication Publication Date Title
DK3405050T3 (da) Børnesikret snusbeholder
DK3319956T3 (da) Substituerede oxopyridinderivater
DK3436823T3 (da) Antigen-array
DK3330593T3 (da) Halo-lysenhed
DK3253762T3 (da) 9h-pyrrolo-dipyridinderivater.
DK3335532T3 (da) Tandharve
DK3445708T3 (da) Stigbøjle
DK3402792T3 (da) Quinolin-2-on-derivater
DK3231803T3 (da) Dihydroindolizinonderivat
DK3509963T3 (da) Pallecontainer
DK3642202T3 (da) Dihydro-pyrrolo-pyridin-derivater
DK3131898T3 (da) Fluoroalkylfluorenderivativer
DK3528829T3 (da) Bacitracin-alginat-oligomer-konjugater
DK3575238T3 (da) Pallecontainer
DK3645513T3 (da) Benzazepinderivater
DE112017006386A5 (de) Schraubarbeitszylinder
DK3452590T3 (da) Plademagnet
DE112017000734A5 (de) Glycolsensor
DK3484889T3 (da) Ethynylderivater
DK3323708T3 (da) Bovfender
DK3452587T3 (da) Penicillin-g-acylaser
DK3380465T3 (da) Diaminopyridinderivativer
DK3471535T3 (da) Dyrelift
DE112017005767A5 (de) Nasslaufende lamellenkupplung
DK3436447T3 (da) Isoquinolinyl-triazolon-komplekser